These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36908034)
1. Ultra-high dose of intravenous immunoglobulin restores strength and motor function in a patient with refractory multifocal motor neuropathy. Saucedo M; León-Cejas L; Marchesoni C; Pardal A; Reisin R Rev Neurol; 2023 Mar; 76(6):209-211. PubMed ID: 36908034 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin therapy in the treatment of multifocal motor neuropathy. Kumar A; Patwa HS; Nowak RJ J Neurol Sci; 2017 Apr; 375():190-197. PubMed ID: 28320129 [TBL] [Abstract][Full Text] [Related]
3. High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy. Nobile-Orazio E; Cocito D; Briani C; Plasmati R; Schenone A; Gallia F; Marjanovic I; Suffredini AL Neurol Sci; 2017 May; 38(5):899-902. PubMed ID: 28144763 [TBL] [Abstract][Full Text] [Related]
4. Steroid-responsive multifocal motor neuropathy with cranial manifestations - a case report. Chen YH; Wei YC; Weng WC; Chien YY; Wu CL Acta Neurol Taiwan; 2024 Mar; 33(1)():28-35. PubMed ID: 37848240 [TBL] [Abstract][Full Text] [Related]
5. [Long-term follow-up of multifocal motor neuropathy with conduction block under intravenous immunoglobulin]. Delmont E; Azulay JP; Uzenot D; Attarian S; Verschueren A; Pouget J Rev Neurol (Paris); 2007 Jan; 163(1):82-8. PubMed ID: 17304176 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin for multifocal motor neuropathy. Keddie S; Eftimov F; van den Berg LH; Brassington R; de Haan RJ; van Schaik IN Cochrane Database Syst Rev; 2022 Jan; 1(1):CD004429. PubMed ID: 35015296 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis. Racosta JM; Sposato LA; Kimpinski K Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063 [TBL] [Abstract][Full Text] [Related]
8. [The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy]. Kubori T; Mezaki T; Kaji R; Kimura J; Hamaguchi K; Hirayama K; Kanazawa I; Miyatake T; Mannen T; Kowa H; Yanagisawa N; Goto I; Osame M; Kanda M; Tashiro K; Baba M; Kuroiwa Y; Nagatomo H; Mitsuma T; Shigeta Y; Saida T; Nakajima K; Kawamura J; Murai Y; Kiuchi T No To Shinkei; 1999 Feb; 51(2):127-35. PubMed ID: 10198901 [TBL] [Abstract][Full Text] [Related]
9. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. Meucci N; Cappellari A; Barbieri S; Scarlato G; Nobile-Orazio E J Neurol Neurosurg Psychiatry; 1997 Dec; 63(6):765-9. PubMed ID: 9416813 [TBL] [Abstract][Full Text] [Related]
10. Dramatic clinical response to ultra-high dose IVIg in otherwise treatment resistant inflammatory neuropathies. Kapoor M; Reilly MM; Manji H; Lunn MP; Aisling S ; Carr Int J Neurosci; 2022 Apr; 132(4):352-361. PubMed ID: 32842835 [TBL] [Abstract][Full Text] [Related]
12. [Multifocal Motor Neuropathy]. Kanda S; Kanda T Brain Nerve; 2024 May; 76(5):526-533. PubMed ID: 38741492 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for multifocal motor neuropathy. van Schaik IN; van den Berg LH; de Haan R; Vermeulen M Cochrane Database Syst Rev; 2005 Apr; (2):CD004429. PubMed ID: 15846714 [TBL] [Abstract][Full Text] [Related]
14. Childhood-onset multifocal motor neuropathy with conduction blocks. Moroni I; Bugiani M; Ciano C; Bono R; Pareyson D Neurology; 2006 Mar; 66(6):922-4. PubMed ID: 16567714 [TBL] [Abstract][Full Text] [Related]
15. Multifocal motor neuropathy. Van Asseldonk JT; Franssen H; Van den Berg-Vos RM; Wokke JH; Van den Berg LH Lancet Neurol; 2005 May; 4(5):309-19. PubMed ID: 15847844 [TBL] [Abstract][Full Text] [Related]
16. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Vucic S; Black KR; Chong PS; Cros D Neurology; 2004 Oct; 63(7):1264-9. PubMed ID: 15477549 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy. Vlam L; Cats EA; Willemse E; Franssen H; Medic J; Piepers S; Veldink JH; van den Berg LH; van der Pol WL J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1145-8. PubMed ID: 24336791 [TBL] [Abstract][Full Text] [Related]
18. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study. Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906 [TBL] [Abstract][Full Text] [Related]
19. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment]. Léger JM; Viala K; Maisonobe T; Bouche P Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061 [TBL] [Abstract][Full Text] [Related]
20. MMN: from immunological cross-talk to conduction block. Harschnitz O; Jongbloed BA; Franssen H; Straver DC; van der Pol WL; van den Berg LH J Clin Immunol; 2014 Jul; 34 Suppl 1(Suppl 1):S112-9. PubMed ID: 24728842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]